HEALTH NEWS
Study Title:
Acquired flucytosine resistance during combination of caspofungin and flucytosine for Candida glabra
Study Abstract
Treatment of Candida glabrata cystitis remains a therapeutic challenge and antifungal combination using flucytosine is one option. We describe 2 patients with refractory C. glabrata cystitis who failed flucytosine combined with caspofungin with early-acquired high-level resistance to flucytosine due to nonsense mutations in the FUR1 gene. Rapid acquired flucytosine resistance with microbiological failure should discourage combination of caspofungin and flucytosine during urinary candidiasis.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.
Study Information
Acquired flucytosine resistance during combination of caspofungin and flucytosine for Candida glabrata cystitis
Antimicrob Agents Chemother.
2015 November
Full Study
http://www.ncbi.nlm.nih.gov/pubmed/26525799Recent News
Arabinogalactan Boosts Lymph Flow and Immunity
Protect Your Gut Mucosal Barrier for Immune Health and Vitality
The Truth About Sugar Substitutes: Are Stevia, Sucralose, and Saccharin Safe?
Boost Your Digestive Power for Better Nutrient Absorption and Gut Health
MTHFR Gene and The Importance of Methyl B12 and Methyl Folate